Cabaletta Bio’s Post

PharmaVoice breaks down the potentially seismic impacts of CRISPR-based therapies, with data from Norstella companies Citeline and Evaluate Ltd and commentary from Jen (Goldenberg) Klarer of The Dedham Group, where Jen underscores the promise and complexity of these treatments. Read the article here: https://ow.ly/pybG50QjgaM. #Pipeline2Patient #Norstella

Semaglutide 2.4mg associated w/20% MACE reduction in patients without T2DM. If you haven’t seen this yet, here you go! This is significant. #weightloss #weightlossjourney #medicationsafety #outcomesresearch #semaglutide More details to be released at upcoming conference. Article linked in comments.

Yes, access is an issue for Sotyktu, but it's not the only one.... According to Spherix Global Insights' latest data, safety perceptions are shifting for Bristol Myers Squibb's Sotyktu. Compared to last year, a growing percentage of dermatologists agree they are hesitant to prescribe Sotyktu despite the "clean" label. These perceptions are now impacting the TYK2 class as fewer physicians report that the TYK2 mechanism fills an unmet need in plaque psoriasis. Although this will likely impact TYK2s in development, this could bode well for other orals in the pipeline for plaque psoriasis. Read more here: https://lnkd.in/eNsd8SCu #Sotyktu #BMS #psoriasis

📊 Take a look at our latest visual abstract presenting data from the phase IV IMMpulse trial, which compared risankizumab to apremilast in chronic plaque #psoriasis 👉 https://loom.ly/7Wy6pX4. #dermtwitter

Thank you to all of the providers who support us and trust BENEV Exosomes with their patients! A special shoutout to… 💧Mari De La Roca, LME (@pinskiderm) …for sharing what her experience has been like while using BENEV Exosomes! *Statements made by each provider are of their own experience and not the statements of BENEV Company Inc. #benevskinscience #benevexosomes #exosomes #exosomeregenerativecomplex #exocobio #benev+exocobio #exosometechnology *Disclaimer: BENEV Exosome Regenerative Complexes are not drug products. They are not intended to prevent, treat, or cure diseases or medical conditions. They are not intended to be injected or delivered intravenously.

Join us today at 4 PM in the Innovation Zone at Phacilitate Advanced Therapies Week 2024 (#ATW2024). We'll be discussing 'Revolutionizing Regenerative Medicine: #BonoFill and #MesenCure - Pioneering Accessible and Economical Advanced Therapies at Bonus Biogroup.' Don't miss this insightful session on groundbreaking advancements in cell therapy and tissue engineering!

Join us today at 4 PM in the Innovation Zone at Phacilitate Advanced Therapies Week 2024 (#ATW2024). We'll be discussing 'Revolutionizing Regenerative Medicine: #BonoFill and #MesenCure - Pioneering Accessible and Economical Advanced Therapies at Bonus Biogroup.' Don't miss this insightful session on groundbreaking advancements in cell therapy and tissue engineering!

📊 Comparing MS treatments - AFFIRM, Reference Natalizumab, and Antelope Biosimilar Natalizumab trials provide valuable insights! 🧪 Stay up-to-date on the latest clinical data to make informed decisions about managing multiple sclerosis: https://ow.ly/hZc650PmZU6

A brief history to the start of XYGene. Stay tuned for more background, what XYGene does, and how we plan on making the medical world a better place! www.xygene.net #seamlesswellness #XYGene #XYGenehealth #precisioncare #precisionmedicine

Congratulations to @sunrisemedicalaesthetics, @engineeredaestheticslv and @aflaesthetic for winning our July Exosomes Reel contest!!! We love how you showcased the different ways to use BENEV Exosomes in your practice and how you are sharing it with your followers! To our winners, check your DMs to claim your prize! And to see their Reels, check out our stories! #benevexosomes #exosomeregenerativecomplex #benevskinscience *Disclaimer: BENEV Exosome Regenerative Complexes are not drug products. They are not intended to prevent, treat, or cure diseases or medical conditions. They are not intended to be injected or delivered intravenously.